What is the latest price of Pirfenidone/Isri in 2025? Price per box and medical insurance reimbursement status
Pirfenidone is an oral anti-fibrotic drug mainly used to treat idiopathic pulmonary fibrosis (IPF). Idiopathic pulmonary fibrosis is a progressive lung disease characterized by the gradual replacement of lung tissue with scar tissue, resulting in decreased respiratory function. Pirfenidone slows down the progression of the disease and improves patients' quality of life by inhibiting a variety of bioactive factors and signaling pathways in the fibrosis process.
In China, the original drug of pirfenidone, Esbriet (Esbriet), has been approved for marketing by the State Food and Drug Administration and has been included in Class B medical insurance, which provides certain financial support to patients who meet the indications. According to the latest market information, each box of pirfenidone contains 100mg*54 tablets and sells for approximately RMB 500. The price is relatively modest, but for many patients, long-term use still poses a significant financial burden.

In addition, with the continuous development of global drug production technology, generic drugs of pirfenidone have also been launched in overseas markets such as India. Taking the Indian market as an example, the specifications of generic drugs are usually 200mg*30 tablets, and the price is about one hundred yuan. This type of medicine is similar in composition to the original medicine, and its efficacy is also recognized to a certain extent, so it is favored by some patients. However, the quality and effectiveness of generic drugs can vary, and patients need to consider their selection carefully.
In terms of purchasing channels, patients can purchase through the hospital’s pharmacy or through the cooperative pharmacy of the medical institution. When purchasing, it is very important to ensure the legality and quality of medicines. Especially when purchasing overseas, you should choose formal channels to ensure your own medication safety. For more information on overseas drug prices and related information, please consult Yaode Medical Consultants.
Reference materials:https://www.esbriet.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)